NEUARTIGE VERWENDUNGEN

Patent europeic · EP3509589 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3509589
Numer da la dumonda
EP17849790
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-09-2017
Publitgà
17-07-2019
Concedì
17-11-2021
La protecziun finescha il pli tard
11-09-2037
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 31/404 (2006.01)
A61K 31/444 (2006.01)
A61K 31/4015 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/4985 (2006.01)
A61K 31/522 (2006.01)
A61P 25/00 (2006.01)
A61P 29/00 (2006.01)
Prioritad
US 201662393386 P 12.09.2016
US 201662412739 P 25.10.2016
US 201762467218 P 05.03.2017
Dumonda PCT
PCT/US2017/051220 12.09.2017
Publicaziun PCT
WO2018/049417 15.03.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 21-05-2026

    Adressa dal represchentant midada

    Representative
    Synergy IP Group AG, Leonhardsgraben 52, Postfach, 4001 Basel → Synergy IP Group AG, Unterer Rheinweg 50, 4057 Basel

    Published in Swissreg on 21.05.2026

  3. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  5. 29-04-2024

    Adressa midada

    Representative
    Pharma Patents International AG, Leonhardsgraben 52, 4051 Basel → Synergy IP Group AG, Leonhardsgraben 52, Postfach, 4001 Basel

    Published in Swissreg on 29.04.2024

  6. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  7. 04-11-2022

    Midada

    Published in Swissreg on 04.11.2022

  8. 28-09-2022

    Midada

    Published in Swissreg on 28.09.2022

2 endataziuns pli veglias
  1. 02-02-2022

    Represchentant inscrit

    Representative
    Pharma Patents International AG, Leonhardsgraben 52, 4051 Basel

    Published in Swissreg on 02.02.2022

  2. 17-11-2021

    Concedì

    Published in Swissreg on 17.11.2021

Partidas

Possessur

Intra-Cellular Therapies, Inc.

430 East 29th Street, Suite 900, New York, NY 10016, US

Represchentant

Synergy IP Group AG

Unterer Rheinweg 50, 4057 Basel

Inventur

SNYDER, Gretchen

New York, New York 10016, US

WENNOGLE, Lawrence P.

New York, New York 10016, US

O'BRIEN, Jennifer

New York, New York 10016, US

HENDRICK, Joseph

New York, New York 10016, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.